For The Better

You may never have heard of this token — at least not by its correct name.

You may never have heard of this token — at least not by its correct name.

The company has already made plenty of investors happy.

The company has already made plenty of investors happy.

These biotechs could skyrocket in 2023, but only if they can execute their plans.

These biotechs could skyrocket in 2023, but only if they can execute their plans.

The company’s strategy will take time to implement, but it’ll make investors a lot richer if it works.

The company’s strategy will take time to implement, but it’ll make investors a lot richer if it works.

It’s been an ugly year for many stocks, but not all of them.

It’s been an ugly year for many stocks, but not all of them.

This steady company can be a great ballast in a growth stock portfolio.

This steady company can be a great ballast in a growth stock portfolio.

The oil company lost some ground last month.

The oil company lost some ground last month.

Weak guidance for the fourth quarter torched the software stock.

Weak guidance for the fourth quarter torched the software stock.

Reports of TSM’s fab capacity utilization rates decreasing could cause headwinds for this chip giant.

Reports of TSM’s fab capacity utilization rates decreasing could cause headwinds for this chip giant.

Inflation has taken a bite out of this e-commerce retailer’s profits, but that doesn’t mean investors should not consider buying Chewy stock.